<p>A. HFK cells were exposed to 10 mJ/cm<sup>2</sup> UVB and immunofluorescence was used to measure the percentage of cells positive for thymine dimers above background. B. HT1080 cells were exposed to 10 mJ/cm<sup>2</sup> UVB and immunofluorescence was used to measure the percentage of cells positive for thymine dimers above background. C. HFK cells were exposed to 10 mJ/cm<sup>2</sup> UVB and immunofluorescence was used to measure the percentage of cells positive for phospho H2AX above background. D. HT1080 cells were exposed to 10 mJ/cm<sup>2</sup> UVB and immunofluorescence was used to measure the percentage of cells positive for phospho H2AX above background. For all portions of this figure, n≥5, error bars represent standard errors of...
<p><b>A</b>: pDC were cultured with CpG in the presence or absence of HepG2.215-derived HBV. Data sh...
<p>Panel A. Upper row, control MC non-producing PAR acclimated PCC7005 strain, middle row - PCC7806 ...
International audienceClinical observations of non-melanoma skin cancer in immunocompromised patient...
<p>HFK cells were exposed to 10 mJ/cm<sup>2</sup> UVB and immunofluorescence was used to measure the...
<p>A. Relative viability of HFK cells expressing HPV 5, 8, 38, and 16 E6 was measured following expo...
<p>A. Median Lethal dose of UVB for HPV E6 expressing primary human foreskin keratinocytes (HFKs) wa...
<p>A. Representative immunoblot showing ATR protein levels in HFK cells either untreated or exposed ...
(A) Outline of an experiment to evaluate FancD2 monoubiquitination/de-ubiquitination pattern. Transd...
<p>HFK cells were exposed to 4 gray of ionizing radiation and immunofluorescence microscopy was used...
<p>(A.) Representative immunoblot showing BRCA1, BRCA2, RPA70 and RAD51 protein levels in HFK cells....
<p>A) WT, DK0064 (ATR–SS), CV1720 (patient), CV1780 (patient's mother) and CV1783 (patient's father)...
<p>Left side: (no extra pigmentation); right side: cells subjected to the pigmentation protocol (M++...
(A) HFK cells were treated with cisplatin (3 uM) for 24 hr and immunostained with FancD2 (red), pH2A...
Chicken DT40 cells (A to B) and human TK6 cells (C to F) carrying the indicated genotypes were expos...
<p>(A.)–(C.) Relative viability of HFK cells exposed to either (A.) ionizing radiation (2 gray) or g...
<p><b>A</b>: pDC were cultured with CpG in the presence or absence of HepG2.215-derived HBV. Data sh...
<p>Panel A. Upper row, control MC non-producing PAR acclimated PCC7005 strain, middle row - PCC7806 ...
International audienceClinical observations of non-melanoma skin cancer in immunocompromised patient...
<p>HFK cells were exposed to 10 mJ/cm<sup>2</sup> UVB and immunofluorescence was used to measure the...
<p>A. Relative viability of HFK cells expressing HPV 5, 8, 38, and 16 E6 was measured following expo...
<p>A. Median Lethal dose of UVB for HPV E6 expressing primary human foreskin keratinocytes (HFKs) wa...
<p>A. Representative immunoblot showing ATR protein levels in HFK cells either untreated or exposed ...
(A) Outline of an experiment to evaluate FancD2 monoubiquitination/de-ubiquitination pattern. Transd...
<p>HFK cells were exposed to 4 gray of ionizing radiation and immunofluorescence microscopy was used...
<p>(A.) Representative immunoblot showing BRCA1, BRCA2, RPA70 and RAD51 protein levels in HFK cells....
<p>A) WT, DK0064 (ATR–SS), CV1720 (patient), CV1780 (patient's mother) and CV1783 (patient's father)...
<p>Left side: (no extra pigmentation); right side: cells subjected to the pigmentation protocol (M++...
(A) HFK cells were treated with cisplatin (3 uM) for 24 hr and immunostained with FancD2 (red), pH2A...
Chicken DT40 cells (A to B) and human TK6 cells (C to F) carrying the indicated genotypes were expos...
<p>(A.)–(C.) Relative viability of HFK cells exposed to either (A.) ionizing radiation (2 gray) or g...
<p><b>A</b>: pDC were cultured with CpG in the presence or absence of HepG2.215-derived HBV. Data sh...
<p>Panel A. Upper row, control MC non-producing PAR acclimated PCC7005 strain, middle row - PCC7806 ...
International audienceClinical observations of non-melanoma skin cancer in immunocompromised patient...